Morning Briefing
Summaries of health policy coverage from major news organizations
Aflatoxin Treatment Project In Kenya Faces Challenge In Marketing Product To Poor Farmers
IRIN examines an 18-month project in Kenya testing a maize treatment aimed at controlling "a deadly fungus, aflatoxin," which has the potential to cause cancer, immune system suppression, growth retardation, liver disease and death among the "literally billions of people in the developing world" who are chronically exposed to the fungus.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
